Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19

NCT05007496 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
145
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aivita Biomedical, Inc.

Collaborators